Kira Biotech attracts Series A
Australian immunology company Kira Biotech has secured A$20 million in Series A funding. OneVentures, IP Group and the Advance Queensland Business Development Fund led the round.
31 October 2019•1 min read
Australian immunology company Kira Biotech has secured A$20 million in Series A funding. OneVentures, IP Group and the Advance Queensland Business Development Fund led the round.
